Clinical Trials Browser

Terminated × Has results × PR-104 × Clear all

NCT00862082 2013-08-23

Randomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)

Phase 1/2 Terminated

14 enrolled 15 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT00544674 2012-12-10

PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer

Phase 2 Terminated

5 enrolled 7 charts

Lung Neoplasms, Small Cell Lung Carcinoma